NASHVILLE, Tenn.--(BUSINESS WIRE)--Harrow (NASDAQ: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for ...
Moxifloxacin is an effective antibiotic for prophylactic use in refractive lens surgery, protecting against ocular infections while maintaining a low toxicity level, according to Edward J. Holland, MD ...
Please provide your email address to receive an email when new articles are posted on . Harrow announced it will begin marketing and selling Vigamox, a fluoroquinolone antibiotic eye drop for ...
MUMBAI and BALTIMORE — Lupin on Wednesday announced the launch of its generic of Vigamox (moxifloxacin hydrochloride, 0.5%) ophthalmic solution. The drug is indicated to treat bacterial conjunctivitis ...
Upsher-Smith and Rafarm are launching moxifloxacin ophthalmic solution, 0.5%. The product is the generic of Novartis' Vigamox. In 2018, Upsher-Smith and Rafarm entered into a partnership agreement to ...
Watson Pharmaceuticals, Inc. is a leading integrated global pharmaceutical company. The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results